Investigação de malondialdeído livre e total por eletroforese capilar visando a análise de amostras de urina e plasma
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Malondialdehyde (MDA) is the most widely used biomarker of lipid peroxidation, and the
development of selective, reliable, and rapid methods for its determination in biological
samples is essential. Thus, the present work aimed to develop and optimize a Capillary Zone
Electrophoresis with Direct UV Detection (CZE – UV) method for the determination of the
MDA biomarker in urine samples from individuals tested for COVID-19 and in plasma samples
from individuals supplemented with omega-3. The electrophoretic mobility of MDA was
determined for the first time, which proved to be of paramount importance for the development
of the CZE – UV method. Implementing an effective mobility x pH curve and simulation in the
PeakMaster®
software allowed the determination of the most appropriate experimental
conditions for the analysis. Thus, the optimized background electrolyte (BGE) comprised TRIS
40 mmol L-1
, HCl 20 mmol L-1
, and CTAB 2.5 mmol L-1
(pH 8.0). It was verified that MDA
presents good absorption in the UV region. Thus, it was monitored at 266 nm. Under these
conditions, MDA was detected in approximately 1 min, so this would be the method for
determining MDA in biological samples by Capillary Electrophoresis (CE) with the shortest
migration time ever developed. It was not possible to detect the free MDA signal in the urine
and plasma samples, even by implementing a preconcentration of the analyte using the fieldamplified sample injection (FASI) technique. The Box-Behnken experimental design was
applied to optimize preconcentration. The factors evaluated in this experimental design were
the BGE concentration, the voltage applied during the electrokinetic injection, and the time of
the electrokinetic injection. To determine total MDA, bound MDA was released into free MDA
by an alkaline hydrolysis. However, no MDA signal could be detected in the plasma sample.
The same hydrolysis procedure in urine samples allowed the detection of an MDA signal, which
was confirmed by fortification with the same. Quantification of total MDA by implementing a
matrix-matched calibration curve minimized the matrix effect. Total MDA was quantified in
75 urine samples from individuals tested for COVID-19, and these values were normalized with
urinary creatinine. However, the MDA concentrations found were very high compared to
studies found in the literature. Thus, the following studies involving sample treatment could be
performed to help understand the high MDA values found in urine samples and promote method
improvement: study of MDA stability in urine after alkaline hydrolysis, measurement of total
MDA in urine samples by the thiobarbituric acid reactive substances (TBARS) assay, which is
the most widely used method for this purpose, and extraction of MDA after alkaline hydrolysis
with a suitable solvent, to avoid the influence of interferents.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

